Latanoprost Stimulates Secretion of Matrix Metalloproteinases in Tenon Fibroblasts Both In Vitro and In Vivo

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 12, 2003, Pages 5182-5188

  Mietz, Holger ^a   Esser, Johannes M ^a   Welsandt, Gerhard ^a   Kociok, Norbert ^a   Hueber, Arno ^a   Joussen, Antonia ^a   Esser, Peter ^a   Krieglstein, Günter K ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; LATANOPROST; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CONJUNCTIVAL BIOPSY; CONTROLLED STUDY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FIBROBLAST; FILTERING OPERATION; FLOW CYTOMETRY; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR FORMATION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOTTING, WESTERN; CELLS, CULTURED; CONJUNCTIVA; FASCIA; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; PROSTAGLANDINS F, SYNTHETIC; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES; UP-REGULATION;

EID: 0344420051     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0462     Document Type: Article

References (41)

1. Cairns JE. Trabeculectomy: preliminary report of a new method. Am J Ophthalmol. 1968;66:673-679.
2. Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J. Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmolgoy. 1995;102:1760-1769.
3. Costa VP, Spaeth GL, Eiferman RA, Orengo-Nania S. Wound healing modulation in glaucoma filtration surgery. Ophthalmic Surg. 1993;24:152-170.
4. Fankhauser F. Wound healing in glaucoma filtering surgery. Amsterdam/New York: Kugler Publications, 1992.
5. Addicks EM, Quigley HA, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol. 1983;101:795-798.
6. Buskirk van EM. Cysts of Tenon's capsule following filtration surgery. Am J Ophthalmol 1982;94:522-527.
7. Hitchings RA, Grierson I. Clinico pathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc UK. 1983;103:84-88.
8. Maumenee AE. External filtering operations for glaucoma: the mechanism of function and failure. Trans Am Ophthalmol Soc. 1960;58:319-328.
9. Teng CC, Chi HH, Katzin HM. Histology and mechanism of filtering operations. Am J Ophthalmol. 1959;47:16-34.
10. Jampel HD, McGuigan LJB, Dunkelberger GR, L'Herault NL, Quigley HA. Cellular proliferation after experimental glaucoma filtration surgery. Arch Ophthalmol. 1988;106:89-94.
11. Khaw PT, Occleston NL, Schultz G, Grierson I, Sherwood MB, Larkin G. Activation and suppression of fibroblast function. Eye. 1994;8:188-195.
12. Lee DA, Lee TC, Corres AE, Kitada S. Effects of mithramycin, mitomycin, daunorubicin, and bleomycin on human subconjunctival fibroblast attachment and proliferation. Invest Ophthalmol Vis Sci. 1990;31:2136-2144.
13. Tahery MM, Lee DA. Pharmacologic control of wound healing in glaucoma filtration surgery. J Ocul Pharmacol. 1989;5:155-179.
14. Broadway D, Hitchings R, Grierson I. Topical antiglaucomatous therapy: adverse effects on the conjunctiva and implications for filtration surgery. J Glaucoma. 1995;4:136-148.
15. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol. 1994;112:1446-1454.
16. Johnson DH, Yoshikawa K, Brubaker RF, Hodge DO. The effect of long-term medical therapy on the outcome of filtration surgery. Am J Ophthalmol. 1994;117:139-148.
17. Lavin MJ, Wormald RPL, Migdal CS, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol. 1990;108:1543-1548.
18. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication, I: the conjunctival cell profile. Arch Ophthalmol. 1994;112:1437-1445.
19. Herreras JM, Pastor JC, Calonge M, Asensio VM. Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology. 1982;99:1082-1088.
20. Meyer E, Scharf Y, Zonis S. Effect of topical timolol on the rabbit and human conjunctiva: ultrastructural study. Glaucoma. 1989;11:55-60.
21. Sherwood MB, Grierson I, Millar L, Hitchings RA. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology. 1989;96:327-335.
22. Mietz H, Schlötzer-Schrehardt U, Strassfeld C, Krieglstein GK. Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva. Invest Ophthalmol Vis Sci. 2001;42:679-687.
23. Cunliffe IA, Richardson PS, Rees RC, Rennie IG. Effect of TNF, IL-1, and IL-6 on the proliferation of human Tenon's capsule fibroblasts in tissue culture. Br J Ophthalmol. 1995;79:590-595.
24. Khaw PT, Ward S, Grierson I, Rice NSC. Effect of β radiation on proliferating human Tenon's capsule fibroblasts. BrJ Ophthalmol. 1991;75:580-583.
25. Khaw PT, Sherwood MB, MacKay LD, Rossi MJ, Schultz G. Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts. Arch Ophthalmol. 1992;110:1150-1154.
26. Yamamoto T, Varani J, Soong HK, Lichter PR. Effects of 5-fluorouracil and mitomycin C on cultured rabbit subconjunctival fibroblasts. Ophthalmology. 1990;97:1204-1210.
27. Hueber A, Esser P, Heimann K, Kociok N, Winter S, Weller M. The topoisomerase I inhibitors, camptothecin and beta-lapachone, induce apoptosis of human retinal pigment epithelial cells. Exp Eye Res. 1998;67:525-530.
28. Morrison TB, Wies JJ, Wittwer CT. Quantification of low-copy transcripts by continuous SYBR green I monitoring during amplification. Biotechniques. 1998;24:954-962.
29. Hueber A, Wiedemann P. Esser P, Heimann K. Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR). Int Ophthalmol. 1996;20:345-350.
30. Weller M, Malipiero U, Rensing EA, Barr PJ, Fontana A. Fas/APO-1 gene transfer for human malignant glioma. Cancer Res. 1995;55:2936-2944.
31. Agapova OA, Ricard CS, Salvador-Silva M, Hernandez MR. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia. 2001;33:205-216.
32. Yan X, Tezel G, Wax MB, Edward DP. Matrix metalloproteinases and tumor necrosis factor α in glaucomatous optic nerve head. Arch Ophthalmol. 2000;118;666-673.
33. Ocklind A. Effect of latanoprost on the extracellular matrix of the ciliary muscle: a study on cultured cells and tissue sections. Exp Eye Res. 1998;67:179-191.
34. Sagara T, Gaton DD, Lindsey JD, Gabelt BT, Kaufman PL, Weinreb RN. Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch Ophthalmol. 1999;117:794-802.
35. Wang N, Lindesy JD, Angert M, Weinreb RN. Latanoprost induces matrix metalloproteinase-1 in human uveal tract organ cultures [ARVO Abstract]. Invest Ophthalmol Vis Sci. 2000;41:S509. Abstract nr 2713.
36. Gaton DD, Sagara T, Lindsey JD, Weinreb RN. Matrix metalloproteinase-1 localization in the normal human uveoscleral outflow pathway. Invest Ophthalmol Vis Sci. 1999;40:363-369.
37. Huang SH, Adamis AP, Wiederschain DG, Shima DT, Shing Y, Moses MA. Matrix metalloproteinases and their inhibitors in aqueous humor. Exp Exe Res. 1996;62:481-490.
38. Gonzales-Avila G, Gineba M, Hayakawa T, Vadillo-Ortega F, Teran L, Selman M. Collagen metabolism in human aqueous humor from primary open-angle glaucoma: decreased degradation and increased biosynthesis play a role in its pathogenesis. Arch Ophthalmol. 1995;113:1319-1323.
39. Di Girolamo N, McCluskey P, Lloyd A, Coroneo MT, Wakefiled D. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:671-679.
40. Kawashima Y, Saika S, Yamanaka O, Okada Y, Ohkawa K, Ohnishi Y. Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human subconjunctival tissues. Curr Eye Res. 1998;17:445-451.
41. Weinrreb RN, Lindsey JD. Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost. Invest Ophthalmol Vis Sci. 2002;43:716-722.